Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ohwaki

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
No Shinkei Geka. Neurological Surgery|August 1, 1997
[Rapidly enlarging supratentorial ependymoma in a child presenting initially with a small calcified lesion: case report]K Ohwaki, T Tanishima, N Yoshimasu, et al.
Biochemical and Biophysical Research Communications|April 17, 1995
ETB-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cellsS Ozaki, K Ohwaki, M Ihara, et al.
Biochemical and Biophysical Research Communications|March 10, 2001
Identification of a potent and nonpeptidyl ccr3 antagonistT Saeki, K Ohwaki, A Naya, et al.
Journal of Periodontal Research|September 1, 1994
Collagenase activity and tissue inhibitor of metalloproteinases-1 (TIMP-1) content in human whole saliva from clinically healthy and periodontally diseased subjectsH Hayakawa, K Yamashita, K Ohwaki, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Discovery of a novel CCR3 selective antagonistA Naya, K Kobayashi, M Ishikawa, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|October 1, 1992
[Dual nuclides SPECT for ventilation and perfusion study]E Goto, K Kawakami, T Takahashi, et al.
European Journal of Pharmacology|February 14, 1995
[3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtypeM Ihara, R Yamanaka, K Ohwaki, et al.
Occupational and Environmental Medicine|April 20, 2005
Blood lead and erythrocyte protoporphyrin levels in association with smoking and personal hygienic behaviour among lead exposed workersK Karita, M Nakao, K Ohwaki, et al.
Journal of Medicinal Chemistry|April 20, 2001
Design, synthesis, and discovery of a novel CCR1 antagonistA Naya, Y Sagara, K Ohwaki, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
No Shinkei Geka. Neurological Surgery|August 1, 1997
[Rapidly enlarging supratentorial ependymoma in a child presenting initially with a small calcified lesion: case report]K Ohwaki, T Tanishima, N Yoshimasu, et al.
Biochemical and Biophysical Research Communications|April 17, 1995
ETB-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cellsS Ozaki, K Ohwaki, M Ihara, et al.
Biochemical and Biophysical Research Communications|March 10, 2001
Identification of a potent and nonpeptidyl ccr3 antagonistT Saeki, K Ohwaki, A Naya, et al.
Journal of Periodontal Research|September 1, 1994
Collagenase activity and tissue inhibitor of metalloproteinases-1 (TIMP-1) content in human whole saliva from clinically healthy and periodontally diseased subjectsH Hayakawa, K Yamashita, K Ohwaki, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Discovery of a novel CCR3 selective antagonistA Naya, K Kobayashi, M Ishikawa, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|October 1, 1992
[Dual nuclides SPECT for ventilation and perfusion study]E Goto, K Kawakami, T Takahashi, et al.
European Journal of Pharmacology|February 14, 1995
[3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtypeM Ihara, R Yamanaka, K Ohwaki, et al.
Occupational and Environmental Medicine|April 20, 2005
Blood lead and erythrocyte protoporphyrin levels in association with smoking and personal hygienic behaviour among lead exposed workersK Karita, M Nakao, K Ohwaki, et al.
Journal of Medicinal Chemistry|April 20, 2001
Design, synthesis, and discovery of a novel CCR1 antagonistA Naya, Y Sagara, K Ohwaki, et al.
Pageof 2